Dearborn Partners LLC increased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 224,627 shares of the pharmacy operator’s stock after buying an additional 2,828 shares during the period. Dearborn Partners LLC’s holdings in Walgreens Boots Alliance were worth $15,349,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in WBA. Massey Quick Simon & CO. LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth $27,000. Cornerstone Advisors Inc. grew its holdings in Walgreens Boots Alliance by 102.4% during the 3rd quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 214 shares in the last quarter. Brand Asset Management Group Inc. grew its holdings in Walgreens Boots Alliance by 40.7% during the 4th quarter. Brand Asset Management Group Inc. now owns 692 shares of the pharmacy operator’s stock worth $47,000 after acquiring an additional 200 shares in the last quarter. Alpha Omega Wealth Management LLC grew its holdings in Walgreens Boots Alliance by 44.8% during the 4th quarter. Alpha Omega Wealth Management LLC now owns 869 shares of the pharmacy operator’s stock worth $59,000 after acquiring an additional 269 shares in the last quarter. Finally, Financial Gravity Companies Inc. acquired a new position in Walgreens Boots Alliance during the 4th quarter worth $59,000. 66.57% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ WBA opened at $70.47 on Tuesday. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $86.31. The company has a quick ratio of 0.36, a current ratio of 0.80 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $66.30 billion, a PE ratio of 11.71, a price-to-earnings-growth ratio of 1.10 and a beta of 0.98.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.43 by $0.03. Walgreens Boots Alliance had a net margin of 3.96% and a return on equity of 22.17%. The business had revenue of $33.79 billion during the quarter, compared to analyst estimates of $33.90 billion. During the same period in the previous year, the business posted $1.28 EPS. The company’s quarterly revenue was up 9.9% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance Inc will post 6.52 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Friday, February 15th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Thursday, February 14th. Walgreens Boots Alliance’s payout ratio is 29.24%.
Several research analysts have weighed in on WBA shares. Needham & Company LLC raised shares of Walgreens Boots Alliance to a “buy” rating and set a $94.00 price objective for the company in a report on Thursday, December 20th. Loop Capital set a $82.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Thursday, December 20th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $92.00 price objective for the company in a report on Friday, November 30th. BidaskClub lowered shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 18th. Finally, Morgan Stanley raised their price objective on shares of Walgreens Boots Alliance from $55.00 to $77.00 and gave the stock an “equal weight” rating in a report on Monday, December 3rd. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $78.83.
In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 7,050 shares of the business’s stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total transaction of $555,610.50. Following the completion of the transaction, the director now directly owns 5,709 shares of the company’s stock, valued at approximately $449,926.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 15.73% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2019/02/12/dearborn-partners-llc-has-15-35-million-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.